WFG Advisors’s Rosetta Genomics Ltd. ROSG Stock Holding History

WFG Advisors’s Portfolio ROSG Stock Details ROSG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-51	Closed	-$2K	–	2342
2013 Q4	$2K	Buy	+51	New	+$1.77K	﹤0.01%	2022

Other funds holding ROSG

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

HCM

Highlander Capital Management Short Hills, New Jersey $292M AUM 22.24% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

SIM

Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return

SKK

Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

WFG Advisors's ROSG Position: Q1 2014 in Review

WFG Advisors sold out of Rosetta Genomics Ltd. (ROSG) in Q1 2014, closing a stake of 51 shares — an estimated $2K sold.

WFG Advisors first reported a position in ROSG in Q4 2013 and held it in 1 quarter. The position peaked at $2K in Q4 2013. 18 funds tracked by Wall St. Rank hold ROSG as of Q1 2014.

WFG Advisors reported no remaining Rosetta Genomics Ltd. position as of Q1 2014 after selling out during the quarter.
WFG Advisors sold 51 Rosetta Genomics Ltd. shares in Q1 2014, an estimated $2K.
WFG Advisors first reported a position in Rosetta Genomics Ltd. in Q4 2013 and held it in 1 quarter.
WFG Advisors's Rosetta Genomics Ltd. position peaked at $2K in Q4 2013.
18 funds tracked by Wall St. Rank held Rosetta Genomics Ltd. as of Q1 2014.

Based on WFG Advisors's 13F filing for Q1 2014, filed 24 Apr 2014.